Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen

The structure of a bacterial superantigen, Staphylococcus aureus enterotoxin B, bound to a human class II histocompatibility complex molecule (HLA-DR1) has been determined by X-ray crystallography. The superantigen binds as an intact protein outside the conventional peptide antigen-binding site of the class II major histocompatibility complex (MHC) molecule. No large conformational changes occur upon complex formation in either the DR1 or the enterotoxin B molecules. The structure of the complex helps explain how different class II molecules and superantigens associate and suggests a model for ternary complex formation with the T-cell antigen receptor (TCR), in which unconventional TCR-MHC contacts are possible.

[1]  G. Bricogne,et al.  Methods and programs for direct‐space exploitation of geometric redundancies , 1976 .

[2]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[3]  D. Ohlendorf,et al.  Structure of toxic shock syndrome toxin 1. , 1993, Biochemistry.

[4]  J. Lamb,et al.  Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins. , 1992, Journal of immunology.

[5]  J. Fraser,et al.  Superantigens--remnants of a past process? , 1993, Research in immunology.

[6]  P. Marrack,et al.  The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells , 1990, The Journal of experimental medicine.

[7]  R. Karr,et al.  Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen , 1992, The Journal of experimental medicine.

[8]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[9]  J. Mollick,et al.  Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity , 1993, The Journal of experimental medicine.

[10]  H. Macdonald,et al.  Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class ii isotypes , 1989, European journal of immunology.

[11]  J. Strominger,et al.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. , 1987, The Journal of biological chemistry.

[12]  P. Marrack,et al.  The Bacterial and Mouse Mammary Tumor Virus Superantigens; Two Different Families of Proteins with the Same Functions , 1993, Immunological reviews.

[13]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[14]  P. Marrack,et al.  Antigen recognition properties of mutant V beta 3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor , 1993, The Journal of experimental medicine.

[15]  C. Janeway,et al.  Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism. , 1991, Journal of immunology.

[16]  S. Harrison,et al.  A system for collection and on-line integration of X-ray diffraction data from a multiwire area detector , 1987 .

[17]  P. Romero,et al.  Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells. , 1990, Journal of immunology.

[18]  H. Robinson,et al.  Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity , 1993, The Journal of experimental medicine.

[19]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[20]  R. Sékaly,et al.  Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules , 1994, The Journal of experimental medicine.

[21]  Eric O Long,et al.  Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E , 1992, The Journal of experimental medicine.

[22]  J. Fraser.  High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR , 1989, Nature.

[23]  D. Wiley,et al.  The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.

[24]  D. Stuart,et al.  Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1 , 1994, Nature.

[25]  M. Blackman,et al.  T cell receptor alpha-chain influences reactivity to Mls-1 in V beta 8.1 transgenic mice. , 1992, Journal of immunology.

[26]  P. Marrack,et al.  Evidence for the effects of a superantigen in rheumatoid arthritis. , 1991, Science.

[27]  B. Echtenacher,et al.  T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor , 1992, The Journal of experimental medicine.

[28]  P. Marrack,et al.  Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Highlander,et al.  Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition. , 1991, Journal of immunology.

[30]  P. Marrack,et al.  Mutations defining functional regions of the superantigen staphylococcal enterotoxin B , 1992, The Journal of experimental medicine.

[31]  M. Chintagumpala,et al.  Staphylococcal toxins bind to different sites on HLA-DR. , 1991, Journal of immunology.

[32]  M. L. Connolly.  Analytical molecular surface calculation , 1983 .

[33]  N. Gascoigne,et al.  Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Jorge Navaza,et al.  On the fast rotation function , 1987 .

[35]  R. Karr,et al.  Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. , 1990, Journal of immunology.

[36]  P. Marrack,et al.  HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells , 1990, The Journal of experimental medicine.

[37]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[38]  J. Fraser,et al.  T‐Cell Receptor β‐Chain Binding to Enterotoxin Superantigens , 1993, Immunological reviews.

[39]  L. Steinman,et al.  Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.

[40]  P. Marrack,et al.  Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens , 1990, Nature.

[41]  J. Thibodeau,et al.  Superantigens of microbial origin. , 1993, Seminars in immunology.

[42]  A. Coutinho,et al.  Vβ17 gene polymorphism in wild-derived mouse strains: Two amino acid substitutions in the Vβ17 region greatly alter T cell receptor specificity , 1990, Cell.

[43]  P. Marrack,et al.  Superantigens: mechanism of T-cell stimulation and role in immune responses. , 1991, Annual review of immunology.

[44]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[45]  A. Brunger.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[46]  P. Marrack,et al.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins , 1993, Infection and immunity.

[47]  R. Geha,et al.  Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. , 1989, Journal of immunology.

[48]  P. Marrack,et al.  Identification of the region of T cell receptor β chain that interacts with the self-superantigen MIs-1a , 1990, Cell.

[49]  Eric O Long,et al.  The α1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1 , 1990, Nature.

[50]  P. Marrack,et al.  Superantigens and their potential role in human disease. , 1993, Advances in immunology.

[51]  C. Benoist,et al.  Superantigens interact with MHC class II molecules outside of the antigen groove , 1990, Cell.

[52]  R. Cook,et al.  Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. , 1991, Journal of immunology.

[53]  A. Lesk,et al.  The outline structure of the T‐cell alpha beta receptor. , 1988, The EMBO journal.

[54]  P. Marrack,et al.  Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta , 1991, The Journal of experimental medicine.

[55]  M. Davis,et al.  Molecular components of T-cell recognition. , 1992, Annual review of immunology.

[56]  S. Swaminathan,et al.  Crystal structure of staphylococcal enterotoxin B, a superantigen , 1992, Nature.

[57]  Eric O Long,et al.  Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1 , 1992, The Journal of experimental medicine.

[58]  R. Hodes,et al.  Influence of T cell receptor V alpha expression on Mlsa superantigen- specific T cell responses , 1992, The Journal of experimental medicine.

[59]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[60]  H. Macdonald,et al.  Skewed T cell receptor Vα repertoire among superantigen reactive murine T cells , 1993 .

[61]  M. Blackman,et al.  Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor , 1993, The Journal of experimental medicine.